Hu R - Search Results

1

An NRP1/MDM2-Targeted D-Peptide Supramolecular Nanomedicine for High-Efficacy and Low-Toxic Liver Cancer Therapy.

Zhou Y, Chen Y, Tan Y, Hu R, Niu MM. Zhou Y, et al. Among authors: hu r. Adv Healthc Mater. 2021 May;10(9):e2002197. doi: 10.1002/adhm.202002197. Epub 2021 Mar 9. Adv Healthc Mater. 2021. PMID: 33690977

2

Digoxin sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine via inhibiting Nrf2 signaling pathway.

Zhou Y, Zhou Y, Yang M, Wang K, Liu Y, Zhang M, Yang Y, Jin C, Wang R, Hu R. Zhou Y, et al. Among authors: hu r. Redox Biol. 2019 Apr;22:101131. doi: 10.1016/j.redox.2019.101131. Epub 2019 Jan 30. Redox Biol. 2019. PMID: 30735911 Free PMC article.

3

AIM2 promotes non-small-cell lung cancer cell growth through inflammasome-dependent pathway.

Zhang M, Jin C, Yang Y, Wang K, Zhou Y, Zhou Y, Wang R, Li T, Hu R. Zhang M, et al. Among authors: hu r. J Cell Physiol. 2019 Nov;234(11):20161-20173. doi: 10.1002/jcp.28617. Epub 2019 Apr 5. J Cell Physiol. 2019. PMID: 30953357

4

Absent in melanoma 2 suppresses epithelial-mesenchymal transition via Akt and inflammasome pathways in human colorectal cancer cells.

Yang Y, Zhang M, Jin C, Ding Y, Yang M, Wang R, Zhou Y, Zhou Y, Li T, Wang K, Hu R. Yang Y, et al. Among authors: hu r. J Cell Biochem. 2019 Oct;120(10):17744-17756. doi: 10.1002/jcb.29040. Epub 2019 Jun 18. J Cell Biochem. 2019. PMID: 31210372

5

ROCK2 Confers Acquired Gemcitabine Resistance in Pancreatic Cancer Cells by Upregulating Transcription Factor ZEB1.

Zhou Y, Zhou Y, Wang K, Li T, Zhang M, Yang Y, Wang R, Hu R. Zhou Y, et al. Among authors: hu r. Cancers (Basel). 2019 Nov 27;11(12):1881. doi: 10.3390/cancers11121881. Cancers (Basel). 2019. PMID: 31783584 Free PMC article.

6

HEATR1 deficiency promotes pancreatic cancer proliferation and gemcitabine resistance by up-regulating Nrf2 signaling.

Zhou Y, Wang K, Zhou Y, Li T, Yang M, Wang R, Chen Y, Cao M, Hu R. Zhou Y, et al. Among authors: hu r. Redox Biol. 2020 Jan;29:101390. doi: 10.1016/j.redox.2019.101390. Epub 2019 Nov 20. Redox Biol. 2020. PMID: 31785531 Free PMC article.

7

Flumethasone enhances the efficacy of chemotherapeutic drugs in lung cancer by inhibiting Nrf2 signaling pathway.

Zhou Y, Zhou Y, Wang K, Li T, Yang M, Wang R, Chen Y, Cao M, Hu R. Zhou Y, et al. Among authors: hu r. Cancer Lett. 2020 Apr 1;474:94-105. doi: 10.1016/j.canlet.2020.01.010. Epub 2020 Jan 16. Cancer Lett. 2020. PMID: 31954771

8

Overproduction of Gastrointestinal 5-HT Promotes Colitis-Associated Colorectal Cancer Progression via Enhancing NLRP3 Inflammasome Activation.

Li T, Fu B, Zhang X, Zhou Y, Yang M, Cao M, Chen Y, Tan Y, Hu R. Li T, et al. Among authors: hu r. Cancer Immunol Res. 2021 Sep;9(9):1008-1023. doi: 10.1158/2326-6066.CIR-20-1043. Epub 2021 Jul 20. Cancer Immunol Res. 2021. PMID: 34285037

9

A Supramolecular Nanomedicine Based on Bendamustine and MDM2-Targeted D-peptide Inhibitor for Breast Cancer Therapy.

Zhou Y, Chen Y, Huang X, Tan Y, Hu R, Li C, Niu MM. Zhou Y, et al. Among authors: hu r. Adv Healthc Mater. 2021 Nov;10(21):e2100980. doi: 10.1002/adhm.202100980. Epub 2021 Sep 23. Adv Healthc Mater. 2021. PMID: 34558228

10

Acquired temozolomide resistance in MGMT^low gliomas is associated with regulation of homologous recombination repair by ROCK2.

Zhang X, Li T, Yang M, Du Q, Wang R, Fu B, Tan Y, Cao M, Chen Y, Wang Q, Hu R. Zhang X, et al. Among authors: hu r. Cell Death Dis. 2022 Feb 10;13(2):138. doi: 10.1038/s41419-022-04590-6. Cell Death Dis. 2022. PMID: 35145081 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,611 results

Search Page

Filters